Nippon Ceramic Co., Ltd. logo

Nippon Ceramic Co., Ltd. (6929)

Market Closed
5 Oct, 06:00 AM
JPX JPX
¥
3,750. 00
+85
+2.3192%
¥
- Market Cap
- P/E Ratio
0.4% Div Yield
87,100 Volume
- Eps
¥ 3,665
Previous Close
Add Transaction
Day Range
3,680 3,755
Year Range
3,350 4,280
Want to track 6929 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6929 closed Monday higher at ¥3,750, an increase of 2.3192% from Friday's close, completing a monthly increase of 2.459% or ¥90. Over the past 12 months, 6929 stock gained 0%.
6929 pays dividends to its shareholders, with the most recent payment made on Mar 01, 2026. The next announced payment will be in In 2 months on Dec 31, 2026 for a total of ¥165.
The last earnings report, released on May 08, 2026, missed the consensus estimates by -53.27%. On average, the company has fell short of earnings expectations by -26.635%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

6929 Chart

Nippon Ceramic Co., Ltd. (6929) FAQ

What is the stock price today?

The current price is ¥3,750.00.

On which exchange is it traded?

Nippon Ceramic Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 6929.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, no market cap data is available.

Has Nippon Ceramic Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Nippon Ceramic Co., Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. David Chien CEO
JPX Exchange
JP3725200004 ISIN
DE Country
1,528 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

OrbusNeich Medical Group Holdings Limited operates as an investment holding company with a primary focus on designing, developing, manufacturing, trading in, selling, and marketing medical devices and instruments aimed at treating coronary and peripheral vascular diseases. The company's operational footprint spans various regions including Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. Founded in 2001 and headquartered in Shatin, Hong Kong, OrbusNeich Medical Group Holdings Limited operates under the umbrella of Harmony Tree Limited as its subsidiary. With its innovative product offerings and a wide-reaching geographic presence, the company plays a pivotal role in advancing the field of vascular intervention and treatment globally.

Products and Services

OrbusNeich Medical Group Holdings Limited offers an extensive portfolio of medical devices specifically designed to cater to the needs of percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The array of products includes:

  • Semi-compliant Balloons: These are utilized for pre-dilatation and lesion preparation in vascular intervention procedures. Semi-compliant balloons are designed to open narrowed vessels before a stent is placed.
  • Scoring Balloons: Used for precise lesion preparation, scoring balloons incorporate cutting elements to score plaque, facilitating more effective dilation in resistant lesions.
  • Coronary Stents: These are mesh-like tubes of thin wire which are implanted into narrowed coronary arteries to help keep them open after angioplasty, thus improving blood flow to the heart muscle.
  • Non-compliant Balloons: Used for post-dilatation, these balloons are deployed to fully expand a stent after it has been placed in a coronary artery. Due to their non-compliant nature, they can achieve higher pressures without changing shape.
  • Specialty Catheters: OrbusNeich provides a variety of catheters designed for specific uses in PCI and PTA procedures, catering to the diverse needs of vascular interventions.

Through its comprehensive product lineup, OrbusNeich Medical Group Holdings Limited supports healthcare professionals in improving patient outcomes in coronary and peripheral vascular disease treatments.

Contact Information

Address: Building 20E, Sha Tin, Hong Kong
Phone: 852 2802 2288